Interaction between cyclosporine and grapefruit juice requires long- term ingestion in stable renal transplant recipients

Pharmacotherapy

Volumn 18, Issue 1, 1998, Pages 23-29

  Brunner, Lane J ^a   Munar, Myrna Y ^b   Vallian, John ^c   Wolfson, Marsha ^c   Stennett, Douglass J ^b   Meyer, Mary M ^c   Bennett, William M ^c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; WATER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; FOOD DRUG INTERACTION; FRUIT JUICE; GRAPE; HUMAN; INGESTION; INTESTINE ABSORPTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; RECIPIENT;

ADULT; AREA UNDER CURVE; BEVERAGES; CITRUS; CYCLOSPORINE; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0031985096     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bennett WM, Norman DJ. Action and toxicity of cyclosporine. Annu Rev Med 1986;37:215-24.
2. Deeg HJ, Storb R, Thomas ED, et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphocytic leukemia. Blood 1985;65:1325-34.
3. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
4. Meyers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988;33:590-600.
5. Ptachcinski RJ, Burckart GJ, Venkataramanan R. Cyclosporine concentration determinations for monitoring and pharmacokinetic studies. J Clin Pharmacol 1986;29:358-66.
6. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala TR. Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther 1985;38:296-300.
7. Maurer G, Lemaire M. Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc 1986;18(6 suppl 5):25-34.
8. McMillan MA. Clinical pharmacokinetics of cyclosporin. Pharmacol Ther 1989;42:135-56.
9. Wang CP, Hartman NR, Venkataramanan R, et al. Isolation of 10 cyclosporine metabolites from human bile. Drug Metab Dispos 1989;17:292-6.
10. Kolars JC, Awni WM, Merion RM, Watkins PB. First-pass metabolism of cyclosporin by the gut. Lancet 1991;338: 1488-90.
11. Hoppu K, Koskimies O, Holmberg C, Hirvisalo EL. Evidence for pre-hepatic metabolism of oral cyclosporine in children. Br J Clin Pharmacol 1991;32:477-81.
12. Pierpoint WS. Flavonoids in the human diet. In: Cody V, Middleton JE, Harborne JB, eds. Plant flavonoids in biology and medicine: biochemical, pharmacological, and structure-activity relationships. New York: Alan R. Liss, 1986:125-40.
13. Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
14. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9.
15. Soons PA, Vogels BA, Roosemalen MC, et al. Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin Pharmacol Ther 1991;50:394-403.
16. Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sci 1996;59:1025-30.
17. Edwards DJ, Bellevue FH III, Woster PM. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996;24:1287-90.
18. Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharm Exp Ther 1992;261:1195-9.
19. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin pharmacol Ther 1993;54:589-94.
20. Albengres E, Tillement JP. Cyclosporin and ketoconazole, drug interaction or therapeutic association? Int J Clin Pharmacol Ther Toxicol 1992;30:555-70.
21. Valantine H, Keogh A, McIntosh N, Hunt S, Oyer P, Schroeder J. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation. J Heart Lung Transplant 1992;11:1-7.
22. Yee GC, Stanley DL, Pessa LJ, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;345:955-6.
23. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39:489-90.
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
25. Luke DR, Brunner LJ, Lopez-Berestein G, Yau JC. Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions. J Pharm Sci 1992;81:208-11.
26. Yau JC, Brunner LJ, Lopez-Berestein G, LeMaistre CF, Luke DR. Therapeutic drug monitoring of cyclosporine-lipoprotein levels. Pharmacotherapy 1991;11:291-5.
27. Cipolle RJ, Canafax DM, Rabatin J, Bowers LD, Sutherland DE, Hrushesky WJ. Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression. Pharmacotherapy 1988;8:47-51.
28. Luke DR, Vadiei K, Brunner LJ. Time-dependent pharmacokinetics and toxicity of cyclosporine. Chronobiol Int 1988;5:353-62.
29. Yee GC, McGuire TR. Pharmacokinetic drug interactions with cyclosporin. 1. Clin Pharmacokinet 1990;19:319-32.
30. Yee GC, McGuire TR. Pharmacokinetic drug interactions with cyclosporin. II. Clin Pharmacokinet 1990;19:400-15.
31. First MR, Schroeder TJ, Michael A, Hariharan S, Weiskittel P, Alexander JW. Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial. Transplant Proc 1993;25:591-4.
32. Gupta SK, Bakran A, Johnson RW, Rowland M. Cyclosporin-erythromycin interaction in renal transplant patients. Br J Clin Pharmacol 1989;27:475-81.
33. Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1992;52:453-7.
34. Smith CL, Hampton EM, Pederson JA, Pennington LR, Bourne DW. Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients. Pharmacotherapy 1994;14:471-81.
35. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-91.
36. Hollander AAMJ, van Rooij J, Lentjes EGWM, et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995;57:318-24.
37. Proppe DG, Hoch OD, McLean AJ, Visser KE. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. Br J Clin Pharmacol 1995;39:337-8.
38. Johnston A, Marsden JT, Hla KK, Henry JA, Holt DW. The effect of vehicle on the oral absorption of cyclosporin. Br J Clin Pharmacol 1986;21:331-3.
39. Ducharme MP, Provenzano R, Dehoorne-Smith M, Edwards DJ. Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol 1993;36:457-9.
40. Min DI, Perry PJ, Okah FO, Ashton K, Martin MF, Hunsicker LG. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation 1996;62:123-5.
41. Johnston A, Holt DW. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;346:122-3.
42. Hollander AAMJ, van der Woude FJ, Cohen A. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;346:123.
43. Yee GC, Lowenthal DT. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;346:123-4.
44. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988;43:630-5.
45. Barone G, Chang CT, Choc MG Jr, et al. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral study group. Transplantation 1996;61:875-80.